Continuous Glucose Monitoring in T1DM, Ticragelor vs DAPT in ACS, Nasal ACE2 Levels and COVID-19 in Children, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 16, 2020 issue

Read the full article here

Related Articles